Performance


BD FocalPoint™ slide profiler

BD FocalPoint™
Slide Profiler

  • Significantly improved performance* over current standard practice (CP) in detection of:

    1.  ASCUS+(p=.0000)
    2.  LSIL (p=.012)
    3.  LSIL+ (p=.0058)
  • Identified more HSIL+ slides.*
  • 33% to 44% improvement in the reduction of false negatives.*
  • 16% reduction in false positives.*
  • Inter- and intra-device precision of 99.6%.*

The Bethesda System Abbreviations
ASCUS -- Atypical squamous cells of undetermined significance
AGUS -- Atypical glandular cells of undetermined significance
LSIL -- Low-grade squamous intraepithelial lesion
HSIL -- High-grade squamous intraepithelial lesion
NILM -- Negative for intraepithelial lesion

Explore the BD FocalPoint™ Slide Profiler Technology.

References
* BD FocalPoint™ Slide Profiler Product Insert.
* There was an insufficient number of smears to determine if this increased detection was statistically significant.

 

Unless otherwise noted, BD, BD logo and all other trademarks are property of Becton Dickinson and Company. © 2013 BD